TrialAnnals of oncology : official journal of the European Society for Medical Oncology2026

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.

R J Motzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.